Bioprocessing Is Becoming a Smarter Manufacturing System
Bioprocessing is becoming more connected, automated, and data-driven. Here is what smarter process control means for biopharma manufacturing.
CRO Data Quality: Why Sponsor Datasets Slow MIDD
CRO data quality decides how fast MIDD models reach regulators. See what a pharmacometric CRO survey reveals about sponsor data, costs, and AI-led fixes.
Could Biological Ageing Be the Next Big Shift in Drug Discovery?
“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."
Synthetic Genetic Codes Move Closer to Programmable Biology
Synthetic genetic codes are moving closer to programmable biology as automated cell-free systems enable faster testing of new protein chemistries in R&D.
Could Roche’s Molecular Glue Deal Signal a New Drug Discovery Race?
Drug discovery in molecular glues gains momentum as Roche partners with Chinese company, Defand Therapeutics.
How Sensor-Enhanced Patient Data Completes the Story of the Trial
How much can clinical trials miss when researchers rely solely on patient-reported outcomes? Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, joins Trisha Pillay to discuss how wearable sensors complement electronic clinical outcome assessments (eCOA).